Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing for recombinant erythropoietin.

Joris R Delanghe1, Mathieu Bollen, Monique Beullens

  • 1Department of Clinical Chemistry, University Hospital, Ghent, Belgium. joris.delanghe@ugent.be

American Journal of Hematology
|October 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal Tubular Epithelial Cells as Central Hubs of Kidney Disease.

Diagnostics (Basel, Switzerland)·2026
Same author

The adeno-associated virus Rep proteins target PP4:SMEK1 by preventing substrate recruitment.

PLoS pathogens·2026
Same author

Special Issue: "Molecular Mechanisms and Regulation in Chronic Kidney Diseases".

International journal of molecular sciences·2026
Same author

The Ethical Aspects of AI in Scientific Publishing.

EJIFCC·2026
Same author

Pharmacological treatment of presbyopia.

Acta clinica Belgica·2026
Same author

Validation study of the Helena V8 UltraCE capillary elecrophoresis analyser.

Clinical chemistry and laboratory medicine·2026
Same journal

High Proportion of PNH Type II Neutrophils Is Associated With Thrombosis in Patients Displaying a PNH Clone ≥ 1.

American journal of hematology·2026
Same journal

Peripheral Blood Lymphocytosis Reflecting an Underlying Thymoma.

American journal of hematology·2026
Same journal

Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young Children.

American journal of hematology·2026
Same journal

Myelodysplastic Syndromes: 2026 Update on Diagnosis, Risk-Stratification and Management.

American journal of hematology·2026
Same journal

Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA.

American journal of hematology·2026
Same journal

Comparative Efficacy of Intranasal, Intramuscular, and Intravenous Vitamin B12 Therapy for Hematological Recovery in Vitamin B12 Deficiency Anemia: A Randomized Controlled Trial.

American journal of hematology·2026
See all related articles

Screening athletes for recombinant human erythropoietin (rhEpo) doping is crucial. Current tests may yield false positives due to non-specific antibodies, necessitating improved detection methods for sports integrity.

Area of Science:

  • Sports Science
  • Biochemistry
  • Anti-Doping

Background:

  • Erythropoietin (Epo) is a hormone stimulating red blood cell production.
  • Recombinant human Epo (rhEpo) is misused in sports for performance enhancement.
  • Anti-doping efforts screen athletes for rhEpo to discourage illicit use.

Purpose of the Study:

  • To evaluate current methods for detecting rhEpo doping in athletes.
  • To address limitations in existing direct and indirect Epo detection tests.
  • To propose improvements for accurate Epo testing in sports.

Main Methods:

  • Direct testing using isoelectric focusing and double immunoblotting to distinguish endogenous from exogenous Epo.
  • Indirect testing to detect hematological changes indicative of Epo administration.

Related Experiment Videos

  • Analysis of potential causes for false-positive rhEpo detection.

    • Main Results:

    • Current World Anti-Doping Agency (WADA) approved tests can produce false-positive results for rhEpo.
    • Non-monospecific antibodies in current tests can lead to misidentification in specific urine samples.
    • Preanalytical improvements and refined testing criteria can enhance direct Epo detection accuracy.

    Conclusions:

    • Existing direct Epo testing methods require refinement to minimize false positives.
    • Indirect tests offer broader detection capabilities but necessitate blood samples.
    • Continued development of accurate Epo detection is vital for maintaining fair play in sports.